![](/img/cover-not-exists.png)
Is there a role for minimal residual disease levels in the treatment of ALL patients who receive allogeneic stem cells?
Schilham, M W, Balduzzi, A, Bader, PVolume:
35
Year:
2005
Language:
english
Pages:
1
DOI:
10.1038/sj.bmt.1704847
File:
PDF, 89 KB
english, 2005